Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes
Authors:
- Taylor M. TrioloTTTaylor M. Triolo
- Andrea K. SteckASAndrea K. Steck
- the Type 1 Diabetes TrialNet Study GroupTGthe Type 1 Diabetes TrialNet Study Group
Open Access
- 30 July 2018
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 42 (2) , 192-199
Abstract
OBJECTIVE There are variable reports of risk of concordance for progression to islet autoantibodies (Ab+) and type 1 diabetes in identical twins (IT) after one twin is diagnosed. We examined development of Ab+ and type 1 diabetes and the effects of genetic factors and common environment on Ab+ in IT, nonidentical twins (NT), and full siblings (FS). RESEARCH DESIGN AND METHODS Subjects from the TrialNet Pathway to Prevention Study (N = 48,026) were screened from 2004 to 2015 for Ab+ (GAD antibody [GADA], insulinoma-associated antigen 2 [IA-2A], and autoantibodies against insulin [IAA]). Of these, 17,226 (157 IT, 283 NT, and 16,786 FS) were followed for Ab+ or type 1 diabetes for a median of 2.1 years. RESULTS At screening, IT were more likely to have positive GADA, IA-2A, and IAA than NT or FS (all P < 0.0001). Younger age, male sex, and genetic factors were significant factors for expression of IA-2A, IAA, one or more Ab+, and two or more Ab+ (all P ≤ 0.03). Initially, Ab+ IT had a 69% risk of diabetes by 3 years compared with 1.5% for initially autoantibody negative (b−) IT. In NT, type 1 diabetes risk by 3 years was 72% for initially multiple Ab+, 13% for single Ab+, and 0% for initially Ab− NT. FS had a 3-year type 1 diabetes risk of 47% for multiple Ab+, 12% for single Ab+, and 0.5% for initially Ab− subjects. CONCLUSIONS Risk of type 1 diabetes at 3 years is high for initially multiple and single Ab+ IT and multiple Ab+ NT. Genetic predisposition, age, and male sex are significant risk factors for development of Ab+ in twins.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (5T32-DK-063687-14)
- American Diabetes Association (1-14-CD-17)
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Allergy and Infectious Diseases
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U01-DK-061010, U01-DK-061034, U01-DK-061042, U01-DK-061058, U01-DK-085465, U01-DK-085453, U01-DK-085461, U01-DK-085463, U01-DK-085466, U01-DK-085499, U01-DK-085504, U01-DK-085505, U01-DK-085509, U01-DK-103180, U01-DK-103153, U01-DK-085476, U01-DK-103266)
- JDRF International
This publication has 28 references indexed in Scilit:
- Twin studies in autoimmune disease: Genetics, gender and environmentJournal of Autoimmunity, 2012
- Glycotoxin and Autoantibodies Are Additive Environmentally Determined Predictors of Type 1 DiabetesDiabetes, 2012
- Harmonization of Glutamic Acid Decarboxylase and Islet Antigen-2 Autoantibody Assays for National Institute of Diabetes and Digestive and Kidney Diseases ConsortiaThe Journal of Clinical Endocrinology & Metabolism, 2010
- The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial resultsPediatric Diabetes, 2009
- Concordance for Islet Autoimmunity among Monozygotic TwinsNew England Journal of Medicine, 2008
- A Study of Diabetes Mellitus Within a Large Sample of Australian TwinsTwin Research and Human Genetics, 2008
- The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetesProceedings of the National Academy of Sciences, 2007
- Extreme genetic risk for type 1A diabetesProceedings of the National Academy of Sciences, 2006
- Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twinsBMJ, 1995
- Reliably Separating Identical From Fraternal TwinsArchives of General Psychiatry, 1975